Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Bioinformatics, |
RCV000180815 | SCV000221777 | pathogenic | Severe myoclonic epilepsy in infancy | 2014-12-20 | criteria provided, single submitter | research | |
Gene |
RCV000188831 | SCV000242460 | pathogenic | not provided | 2017-07-13 | criteria provided, single submitter | clinical testing | p.Pro113Thr (CCC>ACC): c.337 C>A in exon 2 of the SCN1A gene (NM_001165963.1) The Pro113Thr missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a non-conservative amino acid substitution of a non-polar Proline residue with a polar Threonine residue and the loss of a Proline may affect the secondary structure of the SCN1A protein. Pro113Thr alters a highly conserved position in the N-terminal region of the protein and multiple missense mutations at nearby codons have been reported in association with an SCN1A-related disorder. Additionally, in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, based on the currently available information, Pro113Thr is a strong candidate for a disease-causing mutation. This variant has been observed de novo without verified parentage. The variant is found in INFANT-EPI panel(s). |
Labcorp Genetics |
RCV000636365 | SCV000757804 | pathogenic | Early infantile epileptic encephalopathy with suppression bursts | 2021-08-28 | criteria provided, single submitter | clinical testing |